Livne-Bar, Izhar
Maurya, Shubham
Gronert, Karsten
Sivak, Jeremy M.
Funding for this research was provided by:
Canadian Institutes of Health Research (PJT166201)
National Institutes of Health (R01EY030218)
Article History
Received: 2 August 2023
Accepted: 1 January 2024
First Online: 11 January 2024
Declarations
:
: All animal procedures and protocols conformed to the guidelines of the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, and were approved by the University Health Network Animal Care and Use Committee in accordance with relevant Canadian guidelines and regulations.
: Several authors (I. L-B, J.M.S., K.G.) have obtained a US patent for use of lipoxins to treat neurodegeneration.